Suppr超能文献

整合全基因组关联研究(GWAS)和蛋白质定量性状位点(pQTL)数据的多组学关联研究表明,巨噬细胞炎性蛋白-1α(MIP-1α)是勃起功能障碍的潜在药物靶点。

Multi-omics association study integrating GWAS and pQTL data revealed MIP-1α as a potential drug target for erectile dysfunction.

作者信息

Liu Jingwen, Pan Renbing

机构信息

Longyou People's Hospital Affiliated with Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Quzhou, Zhejiang, China.

Department of Urology, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, Zhejiang, China.

出版信息

Front Pharmacol. 2024 Nov 1;15:1495970. doi: 10.3389/fphar.2024.1495970. eCollection 2024.

Abstract

BACKGROUND

Erectile dysfunction (ED) brings heavy burden to patients and society. Despite the availability of established therapies, existing medications have restricted efficacy. Therefore, we utilized a two-sample Mendelian randomization (MR) approach to find the drug targets that might enhance the clinical outcome of ED.

METHODS

Genetic instruments associated with circulating inflammatory proteins were obtained from a genome-wide association study (GWAS) involving 8,293 European participants. Summary statistics for ED were extracted from a meta-analysis of the United Kingdom Biobank cohort compromised of 6,175 cases and 217,630 controls with European descent. We utilized multi-omics method and MR study to explore potential drug targets by integrating GWAS and protein quantity trait loci (pQTL) data. Inverse-variance weighted (IVW) method was applied as the primary approach. Cochran's Q statistics was employed to investigate the presence of heterogeneity. Furthermore, we identify the potential therapeutic drug targets for the treatment of ED utilizing molecular docking technology.

RESULTS

This MR analysis of integrating GWAS and pQTL data showed that macrophage inflammatory protein-1 alpha (MIP-1α) was causally associated with the risk of ED (OR:1.19, 95%CI:1.02-1.39, = 0.023). Meanwhile, the results of the weighted median model were consistent with the IVW estimates (OR:1.26, 95%CI:1.04-1.52, = 0.018). Sensitivity analysis revealed no horizontal pleiotropy and heterogeneity. Furthermore, four anti-inflammatory or tonifying small molecular compounds, encompassing echinacea, pinoresinol diglucoside, hypericin, and icariin were identified through molecular docking technology.

CONCLUSION

This study identified MIP-1α as an underlying druggable gene and promising novel therapeutic target for ED, necessitating further investigation to detect the potential mechanisms by which MIP-1α might impact the development of ED.

摘要

背景

勃起功能障碍(ED)给患者和社会带来沉重负担。尽管有既定的治疗方法,但现有药物的疗效有限。因此,我们采用两样本孟德尔随机化(MR)方法来寻找可能改善ED临床结局的药物靶点。

方法

从一项涉及8293名欧洲参与者的全基因组关联研究(GWAS)中获取与循环炎症蛋白相关的遗传工具。ED的汇总统计数据从对英国生物银行队列的荟萃分析中提取,该队列由6175例病例和217630例欧洲血统对照组成。我们利用多组学方法和MR研究,通过整合GWAS和蛋白质数量性状位点(pQTL)数据来探索潜在的药物靶点。采用逆方差加权(IVW)方法作为主要方法。使用 Cochr an's Q统计量来研究异质性的存在。此外,我们利用分子对接技术确定了治疗ED的潜在治疗药物靶点。

结果

这项整合GWAS和pQTL数据的MR分析表明,巨噬细胞炎性蛋白-1α(MIP-1α)与ED风险存在因果关系(OR:1.19,95%CI:1.02-1.39,P = 0.023)。同时,加权中位数模型的结果与IVW估计值一致(OR:1.26,95%CI:1.04-1.52,P = 0.018)。敏感性分析显示没有水平多效性和异质性。此外,通过分子对接技术鉴定出四种抗炎或滋补小分子化合物,包括紫锥菊、松脂醇二葡萄糖苷、金丝桃素和淫羊藿苷。

结论

本研究确定MIP-1α是ED的一个潜在可药物化基因和有前景的新型治疗靶点,需要进一步研究以检测MIP-1α可能影响ED发生发展的潜在机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28bf/11565697/b5110d07a76c/fphar-15-1495970-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验